Stay updated on Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Access to the NCT03290079 study record is now blocked by a 403 Forbidden page, replacing the previous study content and navigation. The change means users cannot view the trial details on ClinicalTrials.gov until access is restored.
    Difference
    18%
    Check dated 2026-09-21T22:17:18.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    - The page now shows Revision: v3.6.6, replacing the previous v3.6.5, indicating a newer version of the study documentation.
    Difference
    0.1%
    Check dated 2026-08-31T17:23:24.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page revision metadata has been updated to v3.6.5, signaling a minor version update to the study record documentation.
    Difference
    0.1%
    Check dated 2026-08-10T11:42:08.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing the previous v3.6.3. This reflects a newer page version without changing the study details or navigation.
    Difference
    0.1%
    Check dated 2026-07-27T06:30:41.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Footer credits now display the Moffitt Cancer Center branding and the full institution name, along with a new 'Helpful Links Provided by' label, and the site revision tag was updated from v3.6.2 to v3.6.3.
    Difference
    0.2%
    Check dated 2026-07-05T12:47:31.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page now displays a revision tag of v3.6.2, replacing the previous v3.6.0, indicating a recent site update to the page.
    Difference
    0.1%
    Check dated 2026-06-28T08:42:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.